SCHEMBL6877176

SCHEMBL6877176

Cc1ccc(NC(=S)NC2CCC(Nc3cc(N(C)C)c4ccccc4n3)CC2)c(C)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.47
KDM4E B2RXH2 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
LMNA P02545 2/20 0.44
MCHR1 Q99705 2/20 0.42
ADRA2A P08913 1/20 0.42
NPC1 O15118 4/20 0.41
RAB9A P51151 4/20 0.41
MAPT P10636 3/20 0.41
NPSR1 Q6W5P4 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
ALDH1A1 P00352 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
MEN1 O00255 1/20 0.39
HPGD P15428 1/20 0.39
AHR P35869 1/20 0.39
HTT P42858 1/20 0.39
RECQL P46063 1/20 0.39
KMT2A Q03164 1/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6877168 1.00 TP53 (0.47) TP53KDM4ESMN1; SMN2LMNAMCHR1
SCHEMBL6877259 0.91 SMN1; SMN2 (0.44) KDM4ESMN1; SMN2LMNAMCHR1ADRA2A
SCHEMBL6877266 0.91 SMN1; SMN2 (0.44) KDM4ESMN1; SMN2LMNAMCHR1ADRA2A
SCHEMBL6460801 0.91 SMN1; SMN2 (0.43) TP53KDM4ESMN1; SMN2LMNAMCHR1
SCHEMBL6873096 0.91 KDM4E (0.43) KDM4ESMN1; SMN2LMNAMCHR1ADRA2A
SCHEMBL6874078 0.91 MCHR1 (0.41) TP53KDM4ESMN1; SMN2LMNAMCHR1
SCHEMBL6873091 0.91 KDM4E (0.43) KDM4ESMN1; SMN2LMNAMCHR1ADRA2A
SCHEMBL6874083 0.91 MCHR1 (0.41) TP53KDM4ESMN1; SMN2LMNAMCHR1
SCHEMBL6458568 0.91 SMN1; SMN2 (0.43) TP53KDM4ESMN1; SMN2LMNAMCHR1
SCHEMBL6879363 0.91 SMN1; SMN2 (0.46) TP53KDM4ESMN1; SMN2LMNAMCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1464335-A2 Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist Taisho Pharmaceutical Co. Ltd. (JP) 2004-10-06 EP disclosed